Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
A short discussion about the SARS-CoV-2 mRNA-1273 vaccine.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: December 10, 2020
Molecular and Immunologic Signatures are Related to Clinical Benefit from Treatment with Vocimagene Amiretrorepvec (Toca 511) and 5-Fluorocytosine (Toca FC) in Patients with Glioma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 24, 2020
Molecular Analyses Support the Safety and Activity of Retroviral Replicating Vector Toca 511 in Patients.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 22, 2018
Efficient Therapeutic Protein Expression Using Retroviral Replicating Vector with 2A Peptide in Cancer Models.
Journal: Human gene therapy
Published: December 09, 2017
A Retroviral Replicating Vector Encoding Cytosine Deaminase and 5-FC Induces Immune Memory in Metastatic Colorectal Cancer Models.
Journal: Molecular therapy oncolytics
Published: November 14, 2017
Retroviral replicating vector-mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity.
Journal: Neuro-oncology
Published: April 08, 2017
Toca 511 gene transfer and treatment with the prodrug, 5-fluorocytosine, promotes durable antitumor immunity in a mouse glioma model.
Journal: Neuro-oncology
Published: April 08, 2017
Retroviral Replicating Vector Delivery of miR-PDL1 Inhibits Immune Checkpoint PDL1 and Enhances Immune Responses In Vitro.
Journal: Molecular therapy. Nucleic acids
Published: August 11, 2016
Last Updated: 09/26/2026